Literature DB >> 17401593

Factors influencing hospital costs of lung cancer patients in Northern Ireland.

Ian Fleming1, Pauline Monaghan, Anna Gavin, Ciaran O'Neill.   

Abstract

Lung cancer is a major cause of morbidity and mortality. In this paper, the hospital costs incurred by 724 lung cancer patients diagnosed in 2001 were determined by review of case notes. These represented all patients diagnosed with lung cancer in Northern Ireland on whom data existed in that year. Total hospital costs in the 12 months from presentation for the 724 patients were 3.99 million pounds. Average patient costs were 5,956 pounds for patients diagnosed with non-small cell lung cancer and 5,876 pounds for those with small cell lung cancer. The main component of cost was inpatient stay, representing between 62 and 84% of costs depending on cell type. Multivariate analyses revealed significant differences in cost related to staging, co-morbidities, age, and deprivation. Total annual hospital costs were 13 times as high as the estimated enforcement cost of the smoke-free legislation in Northern Ireland.

Entities:  

Mesh:

Year:  2007        PMID: 17401593     DOI: 10.1007/s10198-007-0047-4

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  10 in total

1.  Estimating the direct and indirect costs of lung cancer: a prospective analysis in a Greek University Pulmonary Department.

Authors:  Vasiliki Zarogoulidou; Efharis Panagopoulou; Despina Papakosta; Dimitris Petridis; Konstantinos Porpodis; Konstantinos Zarogoulidis; Paul Zarogoulidis; Malamatenia Arvanitidou
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

2.  Cost effectiveness and health-related quality of life of chemoradiotherapy versus radiation therapy alone in elderly head and neck cancer patients.

Authors:  Tanja Sprave; Vivek Verma; Alexander Fabian; Alexander Rühle; Dimos Baltas; Anca-Ligia Grosu; Nils H Nicolay
Journal:  Strahlenther Onkol       Date:  2022-07-14       Impact factor: 4.033

3.  A cost and benefit study of esophagectomy for patients with esophageal cancer.

Authors:  Chih-Cheng Hsieh; Ching-Wen Chien
Journal:  J Gastrointest Surg       Date:  2009-07-28       Impact factor: 3.452

4.  The effect of in-patient chest physiotherapy in lung cancer patients.

Authors:  Sevgi Ozalevli; Duygu Ilgin; Hayriye Kul Karaali; Serpil Bulac; Atilla Akkoclu
Journal:  Support Care Cancer       Date:  2009-05-28       Impact factor: 3.603

Review 5.  Economics of treatments for non-small cell lung cancer.

Authors:  Christos Chouaid; Kukovi Atsou; Gilles Hejblum; Alain Vergnenegre
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

6.  Estimation of lung cancer diagnosis and treatment costs based on a patient-level analysis in Catalonia (Spain).

Authors:  Julieta Corral; Josep Alfons Espinàs; Francesc Cots; Laura Pareja; Judit Solà; Rebeca Font; Josep Maria Borràs
Journal:  BMC Health Serv Res       Date:  2015-02-21       Impact factor: 2.655

7.  Modelling the cost-effectiveness of public awareness campaigns for the early detection of non-small-cell lung cancer.

Authors:  S Hinde; C McKenna; S Whyte; M D Peake; M E J Callister; T Rogers; M Sculpher
Journal:  Br J Cancer       Date:  2015-05-26       Impact factor: 7.640

8.  Estimated costs of advanced lung cancer care in a public reference hospital.

Authors:  Renata Erthal Knust; Margareth Crisóstomo Portela; Claudia Cristina de Aguiar Pereira; Guilherme Bastos Fortes
Journal:  Rev Saude Publica       Date:  2017-08-17       Impact factor: 2.106

9.  The cost of hospital treatment of advanced stage lung cancer patients in a developing South East European country.

Authors:  Jelena Perin; Bojan Zarić; Jelica Eremić Đođić; Zoran Potić; Marijela Potić; Vanesa Sekeruš; Stella Laskou; Charilaos Koulouris; Athanasios Katsaounis; Efstathios Pavlidis; Stylianos Mantalovas; Dimitrios Giannakidis; Nikolaos Michalopoulos; Aikaterini Amaniti; Fotis Konstantinou; Chrysanthi Sardeli; Yunye Ning; Hui Shi; Haidong Huang; Chong Bai; Qiang Li; Branislav Perin; Ioannis Passos; Christoforos Kosmidis; Isaac Kesisoglou; Konstantinos Sapalidis
Journal:  J Cancer       Date:  2018-07-30       Impact factor: 4.207

10.  "Factors associated with non-small cell lung cancer treatment costs in a Brazilian public hospital".

Authors:  Carla de Barros Reis; Renata Erthal Knust; Claudia Cristina de Aguiar Pereira; Margareth Crisóstomo Portela
Journal:  BMC Health Serv Res       Date:  2018-02-17       Impact factor: 2.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.